Literature DB >> 1720463

Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector.

F Felici1, L Castagnoli, A Musacchio, R Jappelli, G Cesareni.   

Abstract

Practically any oligopeptide can be exposed on the surface of the bacteriophage capsid by fusion to the major coat protein of filamentous bacteriophages. A phage expressing a particular peptide tag can be selected from a mixture of tens of millions of clones, exposing oligopeptides of random sequence, by affinity purification with a protein ligand. In this respect, pVIII can be used as an alternative and complement to the exposition vectors based on the product of gene III (pIII). We have constructed a phagemid vector that contains gene VIII under the control of the pLac promoter. This vector can be conveniently used to construct libraries of oligopeptides with a random amino acid sequence. An antipeptide monoclonal antibody was used to affinity-purify phagemids exposing oligopeptides which can interact with the monoclonal antibody. DNA sequencing of the amino terminus of gene VIII of the recovered clones predicts the synthesis of hybrid proteins whose aminoterminal amino acid sequence is related to that of the oligopeptide used to raise the antibody. In other words, only oligopeptides that bind a very small portion of the immunoglobulin G surface are affinity-purified by this method, implying that the antigen binding site possesses molecular properties that renders it much stickier than the remainder of the molecule.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720463     DOI: 10.1016/0022-2836(91)90213-p

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  64 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins.

Authors:  M Monette; S J Opella; J Greenwood; A E Willis; R N Perham
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

4.  The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.

Authors:  D Enshell-Seijffers; L Smelyanski; J M Gershoni
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

5.  A family of concanavalin A-binding peptides from a hexapeptide epitope library.

Authors:  J K Scott; D Loganathan; R B Easley; X Gong; I J Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

6.  High density peptide microarrays. In situ synthesis and applications.

Authors:  Xiaolian Gao; Jean Philippe Pellois; Younghwa Na; Younkee Kim; Erdogan Gulari; Xiaochuan Zhou
Journal:  Mol Divers       Date:  2004       Impact factor: 2.943

7.  Dcp1 links coactivators of mRNA decapping to Dcp2 by proline recognition.

Authors:  Mark S Borja; Kirill Piotukh; Christian Freund; John D Gross
Journal:  RNA       Date:  2010-12-10       Impact factor: 4.942

Review 8.  The basic structure of filamentous phage and its use in the display of combinatorial peptide libraries.

Authors:  S Cabilly
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

9.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

10.  Recognition specificity of individual EH domains of mammals and yeast.

Authors:  S Paoluzi; L Castagnoli; I Lauro; A E Salcini; L Coda; S Fre'; S Confalonieri; P G Pelicci; P P Di Fiore; G Cesareni
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.